GI

Pharmacotherapy of Peptic Ulcer Disease (PUD)

Introduction Peptic ulcer disease (PUD) encompasses the formation of ulcers in the stomach (gastric ulcer) or duodenum (duodenal ulcer), primarily caused by gastric acid hypersecretion and/or compromised defense of the gastric and duodenal...

Read
Pharmacology

Pharmacotherapy of Bronchial Asthma

Introduction Asthma is a chronic inflammatory disease of the airways, characterized by bronchial hyperresponsiveness, variable airflow obstruction, and repeated episodes of wheezing, coughing, chest tightness, and dyspnea. This condition affects more than 300 million...

Read
Pharmacology

Pharmacotherapy of Cough

Introduction Cough is a protective reflex integral to clearing the airways of irritants, secretions, and foreign matter. Without a properly functioning cough mechanism, the risk of airway obstruction, infection, and subsequent...

Read
ANS

Pharmacotherapy of Parkinson’s Disease

Introduction Parkinson’s disease (PD) is a common neurodegenerative disorder characterized predominantly by motor symptoms including bradykinesia, rest tremor, rigidity, and postural instability. These cardinal clinical features trace back to the degeneration of dopaminergic neurons in the substantia nigra...

Read
Neuropharmacology

Pharmacology of Sedative-Hypnotics

Introduction Sedative-hypnotics are a class of medications primarily utilized to induce sedation (calming) or hypnosis (sleep). These central nervous system (CNS) depressants work by enhancing inhibitory neurotransmission...

Read
Neuropharmacology

Pharmacotherapy of Antidepressants

Introduction Antidepressant medications are a cornerstone of modern psychiatric care, offering relief and long-term stabilization for individuals experiencing major depressive disorder, anxiety disorders, and other...

Read
Antimicrobial

Pharmacotherapy of Tuberculosis (TB)

Introduction Tuberculosis (TB) is a potentially severe infectious disease caused primarily by the bacterium Mycobacterium tuberculosis. While TB most commonly affects the lungs (pulmonary tuberculosis),...

Read
ANS

Pharmacotherapy of Glaucoma

Introduction Glaucoma is a group of progressive ocular disorders characterized by damage to the optic nerve, often associated with elevated intraocular pressure (IOP). Over time,...

Read
ANS

Pharmacology of Sympathomimetics: Mechanisms, Clinical Applications, and Safety

Introduction to Sympathomimetics Sympathomimetic medications—also known as adrenergic agonists—are a diverse group of pharmacological agents that mimic the physiological actions of endogenous catecholamines (e.g., norepinephrine...

Read
Featured

History of Pharmacology

Pharmacology is the science that examines how drugs interact with living systems, encompassing the discovery, composition, properties, therapeutic uses, and toxicology of medications. Its history...

Read